Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Aldosterone – the key to curing high blood pressure?

10.04.2008
Understanding the role of the hormone aldosterone could provide hope of new therapeutic treatments to millions of people who suffer from high blood pressure.

That’s the conclusion of a large body of research being presented today at the annual Society for Endocrinology BES meeting in Harrogate. Aldosterone plays a key role in regulating blood pressure and can affect how susceptible you are to developing hypertension later in life.

Researchers at the Medical Research Council Blood Pressure Unit at the University of Glasgow, led by Prof John Connell, have studied the way in which aldosterone affects blood pressure regulation. Aldosterone is a hormone that is produced by the adrenal glands. It acts on the kidneys to make sure that salt levels in the blood are kept at a safe level. However, it also has important actions to alter heart and blood vessel function. Too much aldosterone increases the risk of stroke and heart failure.

The group found that in older people, higher levels of aldosterone in the bloodstream are associated with high blood pressure, while in young adults, high aldosterone levels indicate you are more likely to subsequently develop hypertension later in life. Individual aldosterone levels are determined by a number of factors. People born with a low birth weight tend to have higher aldosterone levels when they are older. Another important influence is genetics - some people have variants of a gene that controls aldosterone that works more efficiently than others. This means that throughout life, certain individuals will have higher aldosterone levels and are more prone to developing high blood pressure. This also suggests that in the future, we may be able to predict from an early age which individuals are more likely to develop hypertension. Lifestyle modification and new drug treatments might then be targeted specifically at this group of people.

... more about:
»Heart »aldosterone »hypertension »pressure

Approximately 1 in 4 people in the UK have hypertension. The higher your blood pressure, the greater your risk of suffering from a heart attack or a stroke. Evidence suggests that aldosterone may be a causal factor in 10% of patients with high blood pressure(1).

Researcher Prof John Connell said:
“Aldosterone is a key cardiovascular hormone. The higher the level of aldosterone in your blood, the more likely it is that you will suffer from high blood pressure, which will increase your risk of suffering a heart attack or a stroke.

Through our research, we have discovered some of the factors that predispose you to having higher aldosterone levels. We now need to build up a better understanding of how production of aldosterone throughout life is controlled. This could help us to discover how to prevent blood pressure rising with age and also allow us to target new drug treatments for high blood pressure.”

Jennie Evans | alfa
Further information:
http://www.endocrinology.org
http://www.endocrinology.org/meetings/2008/BES2008/prog/prog.aspx

Further reports about: Heart aldosterone hypertension pressure

More articles from Life Sciences:

nachricht The balancing act: An enzyme that links endocytosis to membrane recycling
07.12.2016 | National Centre for Biological Sciences

nachricht Transforming plant cells from generalists to specialists
07.12.2016 | Duke University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NTU scientists build new ultrasound device using 3-D printing technology

07.12.2016 | Health and Medicine

The balancing act: An enzyme that links endocytosis to membrane recycling

07.12.2016 | Life Sciences

How to turn white fat brown

07.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>